About Massachusetts General Hospital, Lurie Center for Autism
Clinical Trials at Massachusetts General Hospital, Lurie Center for Autism
During the past decade, Massachusetts General Hospital, Lurie Center for Autism conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital, Lurie Center for Autism"
#1 collaborator was "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Autism Speaks" with 1 trials as a collaborator, "Crisis Prevention Institute" with 1 trials as a collaborator, "Nancy Lurie Marks Family Foundation" with 1 trials as a collaborator and "The Emmes Company, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Massachusetts General Hospital, Lurie Center for Autism
According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital, Lurie Center for Autism" are
"Autism Spectrum Disorder" (3 trials), "Anxiety" (1 trials), "Autism" (1 trials), "Autism Spectrum Disorder (ASD)" (1 trials) and "Autism Spectrum Disorders" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital, Lurie Center for Autism" in a lesser frequency.
Clinical Trials Intervention Types at Massachusetts General Hospital, Lurie Center for Autism
Most popular intervention types in "Massachusetts General Hospital, Lurie Center for Autism" are "Drug" (8 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Aripiprazole" (1 trials), "Atomoxetine" (1 trials), "Buspirone" (1 trials) and "Endocrine Therapy of Physician's Choice" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Massachusetts General Hospital, Lurie Center for Autism
The vast majority of trials in "Massachusetts General Hospital, Lurie Center for Autism" are
10 trials for "All" genders.
Clinical Trials Status at Massachusetts General Hospital, Lurie Center for Autism
Currently, there are NaN active trials in "Massachusetts General Hospital, Lurie Center for Autism".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Massachusetts General Hospital, Lurie Center for Autism,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Massachusetts General Hospital, Lurie Center for Autism, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".